Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Relapse Prevention Through Social Networking Groups

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02007369
Recruitment Status : Completed
First Posted : December 10, 2013
Results First Posted : November 11, 2016
Last Update Posted : January 4, 2017
Sponsor:
Collaborator:
Tung Wah Hospital
Information provided by (Responsible Party):
The University of Hong Kong

Brief Summary:
According to the Census & Statistics Department, there are still 659,300 daily smokers (11.1%) in Hong Kong. Smoking is addictive, and it is difficult for some motivated smokers to quit without assistance. About 33.2% daily smokers in Hong Kong had tried quitting but they could not maintain abstinence. Relapse prevention is aimed at providing interventions to prevent relapse after starting the abstinence status. This pilot single-blind randomized controlled trial (proof of concept study) will test the effectiveness of social networking services for relapse prevention. The study will first recruit 6 quitters and 6 relapsers for a qualitative interview for the design of intervention. Then, the pilot-RCT trial will recruit 120 participants who have recently quitted smoking, and they will be randomly allocated to 2 intervention groups and one control group. The 2 intervention groups will be arranged to join a WhatsApp or Facebook group for receiving quitting advices from the group moderators and sharing quitting experience with other participants. All participants will receive a self-help booklet of relapse prevention, and will be followed up at 6 weeks, 3 months and 6 months. The primary outcome is the self-report relapse rate (Relapse is tentatively defined as smoking 5 cigarettes in 3 consecutive days since joining the RCT among the 3 study arms.

Condition or disease Intervention/treatment Phase
Smoking Behavioral: WhatsApp Behavioral: Facebook Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 136 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Effectiveness of Using Social Networking Service to Prevent Smoking Relapse Among Self-reported Quitters: A Pilot Randomized Control Trial
Study Start Date : January 2014
Actual Primary Completion Date : September 2014
Actual Study Completion Date : February 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Smoking

Arm Intervention/treatment
Experimental: WhatsApp
Provide peer support and deliver relapse prevention messages through WhatsApp for 8 weeks and telephone follow ups
Behavioral: WhatsApp
Intervention arm with relapse prevention intervention in the social group via the social networking service WhatsApp and the duration of the intervention will be 8 weeks.

Experimental: Facebook
Provide peer support and deliver relapse prevention messages through Facebook for 8 weeks and telephone follow ups
Behavioral: Facebook
Another intervention arm with the same intervention content, but the platform for the participants to share and receive quitting advice is Facebook and the duration of the intervention will be 8 weeks.

No Intervention: Control
Telephone follow ups and received a self-help book only



Primary Outcome Measures :
  1. Self Reported Relapse Rate at 2 Months [ Time Frame: 2 months after joining the groups for the social networking services. ]
    Relapse is defined as smoking 5 cigarettes in 3 consecutive days since the most recent quitting. A questionnaire asking smoking status, quitting experience and difficulty in quitting was designed to assess the self reported relapse rate at 2 months.

  2. Self Reported Relapse Rate at 6 Months [ Time Frame: 6-months ]
    Relapse is defined as smoking 5 cigarettes in 3 consecutive days since the most recent quitting. A questionnaire asking smoking status, quitting experience and difficulty in quitting was designed to assess the self reported relapse rate at 6 months.


Secondary Outcome Measures :
  1. Point Prevalence of Self Reported Abstinence for the Previous 7 Days at 2 Months [ Time Frame: 2 months ]
    The outcome was assessed by any self-reported cigarette consumption in the past 7 days at the time of the follow-up. A questionnaire asking smoking status, quitting experience and difficulty in quitting was designed to assess the self reported abstinence for the previous 7 days at 2 months.

  2. Point Prevalence of Self Reported Abstinence for the Previous 7 Days at 6 Months [ Time Frame: 6 months ]
    The outcome was assessed by any self-reported cigarette consumption in the past 7 days at the time of the follow-up. A questionnaire asking smoking status, quitting experience and difficulty in quitting was designed to assess the self reported abstinence for the previous 7 days at 6 months.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Smoked at least 1 cigarette a day when first joined ICSC
  • Aged 18 or above at the baseline of the RCT
  • Clients who have received 3 to 5 smoking cessation counseling provided by ICSC
  • Reported tobacco abstinence in the past 7 days at the 8-week follow-up since receiving treatment from ICSC
  • Able to communicate in Cantonese and read Chinese
  • Have a local network mobile phone with mobile internet access

Exclusion Criteria:

  • Those with unstable physical or psychological conditions as advised by the doctor or counselor in charge
  • Smokers with diagnosed alcohol dependence by clinicians or the score of the Alcohol Use Disorders Identification Test (AUDIT) is 8 or higher

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02007369


Locations
Layout table for location information
China
Integrated Centres on Smoking Cessation (ICSC), Tung Wah Groups of Hospital (TWGH)
Hong Kong, China
Sponsors and Collaborators
The University of Hong Kong
Tung Wah Hospital
Investigators
Layout table for investigator information
Principal Investigator: Tai Hing Lam, MD The University of Hong Kong
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: The University of Hong Kong
ClinicalTrials.gov Identifier: NCT02007369    
Other Study ID Numbers: TWRP2013
First Posted: December 10, 2013    Key Record Dates
Results First Posted: November 11, 2016
Last Update Posted: January 4, 2017
Last Verified: November 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Recurrence
Disease Attributes
Pathologic Processes